Brain initiative cell atlas network (bican) sequencing core task areas 1 through 7 contract type: IDIQ - task order contract maximum: $149,000,000 (cumulative) contract minimum: $10,000 (per…

Active Awarded Last action

Contract number
75N95023D00007
Awardee
Awarding agency
Task orders
2 $22,713,038 obligated

Award facts

Opportunity
Combined order value
  • $22,713,038 Current, with exercised options
  • $69,901,312 Potential, with all options
Last date to order 53% complete
IDV ceiling 15% used
$149,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Institute of Mental Health National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institutes of Health's National Institute on Drug Abuse (NIDA) awarded a $149 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the New York Genome Center, Inc. (doing business as Nygc) to provide sequencing services for the BRAIN Initiative Cell Atlas Network (BICAN). Under this master IDIQ, NIDA has issued two task orders to Nygc totaling over $110 million for brain cell sequencing work. The first $73.8 million task order is for unspecified BICAN sequencing services, while the $38,000 second task order is for developing the BICAN Manual of Operations. Nygc is a non-profit academic research institution that specializes in genomic research and services, particularly in areas like neurodegenerative, neuropsychiatric, and cancer diseases. The BICAN IDIQ and associated task orders do not have set-aside designations, reflecting the specialized nature of the required sequencing capabilities. This IDIQ contract supports the NIH BRAIN Initiative's broader efforts to build comprehensive reference atlases of brain cell types across human, non-human primate, and mouse models.

Description

Brain initiative cell atlas network (bican) sequencing core task areas 1 through 7 contract type: IDIQ - task order contract maximum: $149,000,000 (cumulative) contract minimum: $10,000 (per awardee) task ordering period 01/23/2023 to 01/22/2038

Task orders

Transactions

Action Obligated Date
Change Order P00001 · Brain initiative cell atlas network (bican) sequencing core $0
Original award $0

Quick answers

Who was awarded contract 75N95023D00007?

75N95023D00007 was awarded to New York Genome Center, Inc. by National Institute on Drug Abuse (National Institutes of Health) on January 31, 2023.

How much is contract 75N95023D00007 worth?

Orders under 75N95023D00007 have obligated $22,713,038. Their combined potential value, with all options, is $69,901,312. 75N95023D00007's own ceiling is $149,000,000.

How many orders have been placed under contract 75N95023D00007?

2 orders have been placed under 75N95023D00007, the latest on May 29, 2023.

Which agency awarded contract 75N95023D00007?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023D00007, with funding from National Institute of Mental Health (National Institutes of Health).

Who can order from contract 75N95023D00007?

75N95023D00007 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N95023D00007 part of a contract vehicle?

Yes. 75N95023D00007 is part of BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core.

Was contract 75N95023D00007 competed?

The extent of competition for 75N95023D00007 was full and open competition. The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV